CN108245559A - Secret ointment - Google Patents
Secret ointment Download PDFInfo
- Publication number
- CN108245559A CN108245559A CN201810276677.6A CN201810276677A CN108245559A CN 108245559 A CN108245559 A CN 108245559A CN 201810276677 A CN201810276677 A CN 201810276677A CN 108245559 A CN108245559 A CN 108245559A
- Authority
- CN
- China
- Prior art keywords
- parts
- secret
- radix
- mixture
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of secret ointment, raw material includes the drug based on following mass fraction：7 30 parts of calamine, 10 40 parts of safflower, 15 60 parts of myrrh, 14 50 parts of Radix Notoginseng, 7 30 parts of Radix Angelicae Sinensis, 15 60 parts of the radix paeoniae rubrathe, 15 50 parts of dalbergia wood, 10 40 parts of motherwort, 10 40 parts of cortex acanthopanacis.Secret ointment of the present invention has eliminating stasis to resolve swelling, the effect of relieving pain.
Description
Technical field
The invention belongs to the technical field of Chinese patent medicine preparation, more particularly to a kind of secret ointment.
Background technology
Bone and joint diseases are a kind of common diseases, with arthroncus, stiff, pain, joint stuffiness and influence normally to produce
The joint movement disorder of labour and daily life disease.
Theory of traditional Chinese medical science thinks：Shen controls bone, liver governing tendons, it is different due to constitution, with advancing age and the nutrition intake day after tomorrow
The reasons such as deficiency, the prosperity and decline that each physiological stage of people is all likely to occur hepatic and renal function is biased, as hepatic and renal function and human righteousness
When weak, human body is highly prone to many infringements such as natural environment apoplexy, wet, fever and chills, strain, once the exopathogens such as wind, wet, fever and chills are stagnant
It terminates in human body, the normal operation of qi-blood-body fluid certainly will be influenced, if perverse trend, numbness resistance train of thought phlegm-blood stasis is attached to tendon and vessel joint, muscle
Arteries and veins muscle cannot get nutrition, and metabolin cannot excrete in time, periarticular tissue there have been the swelling such as inflammation, extravasated blood,
Stiff, pain, joint stuffiness even cause the hyperplasia of normal structure, deformation, and obstacle is formed, and then go out to normal physiological movement
Existing pathological symptom.
At present, it for the treatment of above-mentioned pathological symptom, is mostly attached using plaster, the modes such as small needle knife or operation are treated.
Wherein, small needle knife or operative treatment, though quick, patient suffering is big when there is treatment, postoperative easy recurrence and costly etc.
Defect；Plaster attach treatment cost it is low, treatment when patient suffering it is small, but existing finished product plaster there are it is effective in cure it is poor, take effect
Slowly, the easy allergy of patient and the defects such as cure rate is low.
Invention content
The invention is intended to provide a kind of secret ointment of promoting blood circulation.
In order to achieve the above objectives, basic technology scheme of the invention is as follows：Secret ointment, raw material are included by following quality
The drug of number meter：7-30 parts of calamine, 10-40 parts of safflower, 15-60 parts of myrrh, 14-50 parts of Radix Notoginseng, 7-30 parts of Radix Angelicae Sinensis, the radix paeoniae rubrathe
15-60 parts, 15-50 parts of dalbergia wood, 10-40 parts of motherwort, 10-40 parts of cortex acanthopanacis.
The advantageous effect of this programme：Calamine external application can inhibit local aureus growth.Surface of a wound secretion can be partially absorbed
Liquid has convergence, protective effect；The staphylococcic growth in part can still be inhibited.Safflower swells and ache available for traumatic stasis, ulcer sore pain
Wait diseases.Myrrh cures mainly chest and abdomen stasis caused pain, dysmenorrhoea, Amenorrhea, abdominal mass, traumatic injury, carbuncle swells sore, acute appendicitis, red eye, swell pain.Myrrh is to controlling
Mouth, the dermatitis effect of curing the wound are fine, there is promoting blood circulation and stopping pain, detumescence and promoting granulation and other effects.It is a kind of promoting blood circulation in east, stagnation resolvation, analgesic, is good for
The Chinese medicine of stomach.Radix Notoginseng is used for traumatic hemorrhage, chest and abdomen shouting pain, tumbling and swelling.Radix Angelicae Sinensis can benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturize laxation,
Anticancer, anti-ageing the effect of preventing always, is immune.The radix paeoniae rubrathe is used for injury from falling down, carbuncle swells sore.Dalbergia wood is good analgestic, and controls knife
Hinder bleeding.Motherwort promoting blood circulation for regulating menstruation, inducing diuresis to remove edema are clearing heat and detoxicating.Chinese medicine cortex acanthopanacis has wind-damp dispelling, filling liver kidney, strengthening the bones and muscles etc.
Effect.Eliminating stasis to resolve swelling relieves pain.
Further, raw material includes the drug based on following mass fraction：7 parts of calamine, 10 parts of safflower, 15 parts of myrrh,
14 parts of Radix Notoginseng, 7 parts of Radix Angelicae Sinensis, 15 parts of the radix paeoniae rubrathe, 15 parts of dalbergia wood, 10 parts of motherwort, 10 parts of cortex acanthopanacis.As preferably using the formula
Secret plaster curative effect is more obvious.
Further, its raw material of the drug based on following mass fraction includes the drug based on following mass fraction：Calamine
30 parts, 40 parts of safflower, 60 parts of myrrh, 50 parts of Radix Notoginseng, 30 parts of Radix Angelicae Sinensis, 60 parts of the radix paeoniae rubrathe, 50 parts of dalbergia wood, 40 parts of motherwort, cortex acanthopanacis
40 parts.It is more obvious as the secret plaster curative effect preferably using the formula.
Further, raw material includes the drug based on following mass fraction：24 parts of calamine, 35 parts of safflower, 57 parts of myrrh,
43 parts of Radix Notoginseng, 24 parts of Radix Angelicae Sinensis, 54 parts of the radix paeoniae rubrathe, 43 parts of dalbergia wood, 33 parts of motherwort, 36 parts of cortex acanthopanacis.As preferably using the formula
Secret plaster curative effect it is more obvious.
Further, raw material include 30 parts of 20 parts of 15 parts of drug calamine, safflower, myrrh based on following mass fraction,
25 parts of Radix Notoginseng, 15 parts of Radix Angelicae Sinensis, 30 parts of the radix paeoniae rubrathe, 25 parts of dalbergia wood, 20 parts of motherwort, 20 parts of cortex acanthopanacis.As preferably using the formula
Secret plaster curative effect it is more obvious.
Further, secret ointment is made of following steps,
Step (1)：Calamine, safflower, myrrh, Radix Notoginseng, Radix Angelicae Sinensis, the radix paeoniae rubrathe, dalbergia wood, motherwort and cortex acanthopanacis are crushed
Into powdered, mixing of being sieved obtains the mixture A of powdery；
Step (2)：200 parts -600 parts of edible vegetable oil is taken to be put into pot, decocts the 20-40 minutes oil for forming drops
Liquid；
Step (3)：12 parts -24 parts of yellow lead is taken to add in the fluid of step (2), mixture B is obtained, mixture B is passed through
It receives cream device to be stirred evenly and heated, temperature control is spent at 100 degree -210, obtains mixture C；
Step (4)：Mixture A in step (1) is put into receipts cream device, and is carried out with the mixture C of step (3)
It is mixed to prepare plaster.
The advantageous effect of this programme is：
Drug is carried out to receive cream and heating making by receiving cream device, the vegetable oil in mixture B and yellow lead is effective
Ingredient is sufficiently mixed melting, and when mixture B is mixed with mixture A, by receiving cream device mixture B and mixture A
Uniformly mixing and the utilization rate by receiving cream device raising active ingredients from traditional Chinese medicinal, are orally absorbed by human body,
It can retain and play the pharmacological property of each ingredient to the greatest extent.
Description of the drawings
Fig. 1 is the structure diagram that cream device is received in the embodiment of the present invention.
Specific embodiment
Below by the further details of explanation of specific embodiment：
Reference numeral in Figure of description includes：Conveyer belt 1, conveying pipeline 2, sliding rail 3, heating plate 4, heating chamber 5, charging
Hole 6, through-hole 7, shaft 8, the first air pump 9, drug feed pipe 10, horizontal tube 11, spine 12, VERTICAL TUBE 13, the first nozzle 14,
One housing 15, feeding pipe 16, the second housing 17, the second nozzle 18, appendix 19, the second air pump 20.
Following is specific embodiment 1-4：
| Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | |
| Calamine | 7g | 15g | 24g | 30g |
| Safflower | 10g | 20g | 35g | 40g |
| Myrrh | 15g | 30g | 57g | 60g |
| Radix Notoginseng | 14g | 25g | 43g | 50g |
| Radix Angelicae Sinensis | 7g | 15g | 24g | 30g |
| The radix paeoniae rubrathe | 15g | 30g | 54g | 60g |
| Dalbergia wood | 15g | 25g | 43g | 50g |
| Motherwort | 10g | 20g | 33g | 40g |
| Cortex acanthopanacis | 10g | 20g | 36g | 40g |
The secret plaster of the present invention is prepared based on embodiment 1-4 medication dosings, which is：
Step (1)：Calamine, safflower, myrrh, Radix Notoginseng, Radix Angelicae Sinensis, the radix paeoniae rubrathe, dalbergia wood, motherwort and cortex acanthopanacis are crushed
Into powdered, mixing of being sieved obtains the mixture A of powdery；
Step (2)：400 parts of edible vegetable oil is taken to be put into pot, decocts the 35 minutes fluid for forming drops；
Step (3)：22 parts of yellow lead is taken to add in the fluid of step (2), obtains mixture B, mixture B is filled by receiving cream
It puts and is stirred evenly and heated, temperature is controlled at 181 degree, obtains mixture C；
Step (4)：Mixture A in step (1) is put into receipts cream device, and is carried out with the mixture C of step (3)
It is mixed to prepare plaster.
For the receipts cream device used in step (3) and step (4) as shown in Figure 1, including rack, rack is equipped with conveying mechanism
And chemical spraying mechanism, conveying mechanism include conveying pipeline 2, the conveyer belt 1 across delivery pipe lower part and the electricity for the operation of conveyer belt 1
Machine, conveying inside pipe wall both sides are equipped with sliding rail 3, and sliding rail 3 moves downward along sliding rail 3 equipped with several and can be placed in transmission
With the heating plate 4 on 1, the heating chamber 5 for storing plaster is offered in heating plate 4, offers in delivery pipe and is worn for heating plate 4
The charging hole 6 crossed；Chemical spraying mechanism includes the first air pump 9, the horizontal tube 11 being connect with the first air pump 9 and is connected with horizontal tube 11
VERTICAL TUBE 13,13 upper end of VERTICAL TUBE, which is equipped with, is fixed on 13 side wall of VERTICAL TUBE and towards the spine 12 of horizontal tube 11, VERTICAL TUBE
13 lower ends are provided with the first nozzle 14 of conveyer belt 1, horizontal tube 11 be equipped with for the drug that drug after crushing is launched into
Expects pipe 10.
Above-mentioned 2 right side of conveying pipeline is fixedly connected with feeding pipe 16, and 1 upper bit of conveyer belt stretches to feeding pipe 16
Lower part is respectively equipped with the first housing 15 and the second housing 17 connected with feeding pipe 16 in 16 top of feeding pipe, bottom, the
One housing 15 is symmetrical set with the second housing 17 with 16 cross central line of feeding pipe.
Above-mentioned conveyer belt 1 is mounted between two drives, and drive is fixed in rack, and on the output shaft of motor
Shaft 8 is installed, drive is fixed in shaft 8, starts motor, and shaft 8 drives drive rotation clockwise so that conveyer belt
1 moves right.Several through-holes 7 being spaced substantially equidistant are offered on conveyer belt 1, and are provided with leading in the second housing 17
Second nozzle 18 in hole 7, i.e. the second nozzle 18 are extended upwardly on the conveyer belt 1 of 16 lower part of feeding pipe, under 2 right side of conveying pipeline
Portion is equipped with the second air pump 20, and the second air pump 20 is equipped with the appendix 19 connected with the second air pump 20, appendix 19 and second
Nozzle 18 connects.And the first nozzle 14 is arranged in the first housing 15, the first nozzle 14 and the second nozzle 18 are with feeding pipe 16
Cross central line is symmetrical set.
The operation of the present apparatus is as follows：Start motor, the first air pump 9 and the second air pump 20, at this moment, operator is by mixture B
Be put into the heating chamber 5 in each heating plate 4, start heating plate 4 so that heating plate 4 to the mixture B in heating chamber 5 into
Row heating, meanwhile, each heating plate 4 is sequentially placed into conveying pipeline 2 by operator, and heating plate 4 is slided down to along sliding rail 3
On conveyer belt 1.
When heating plate 4 is arrived to conveyer belt 1, conveyer belt 1 is moving right, and then 1 upper surface of conveyer belt and heating plate 4
Lower surface generates friction, the active force that heating plate 4 is moved right by conveyer belt 1 so that cunning of the heating plate 4 out of conveying pipeline 2
Rail 3 is detached from, and with conveyer belt 1 move and move (i.e. object of reference is conveying pipeline 2, heating plate 4 and conveyer belt 1 for together to
Left movement).And then heating plate 4 passes through the charging hole 6 on conveying pipeline 2 to enter in feeding pipe 16, at this moment, the second air pump 20 generates
Gas the second nozzle 18 is delivered to by appendix 19, gas is sprayed to 1 lower surface of conveyer belt by the second nozzle 18, same with this
When, operator puts into the drug after crushing to drug feed pipe 10, and the gas that the first air pump 9 generates rushes at the medicine after crushing
Object so that drug after crushing along horizontal tube 11 manage in enter in VERTICAL TUBE 13, in the process, the drug meeting after crushing
Spine 12 is struck, spine 12 again crushes the drug after crushing so that drug crushes more fine, the drug
It is sprayed to through the first nozzle 14 in the heating chamber 5 on conveyer belt 1.
In whole process, on the one hand the impact of 18 gas of the second nozzle drives the vibrations of conveyer belt 1 so that in heating chamber 5
Mixture B and powdery medicine carry out vibrations and be uniformly mixed；On the other hand it is entered in feeding pipe 16 across through-hole 7, band
Walk the hot gas of 5 inside points of heating chamber so that the temperature in heating chamber 5 reduces.
The secret plaster that the receipts cream device is made has the following effects：
1st, mixture B is heated by heating plate, then mixture B is transported to by conveyer belt and adds in mixture A
The first nozzle, in the process, on the one hand the vegetable oil in mixture B and yellow lead active ingredient can be sufficiently mixed molten
Solution when another aspect mixture B is mixed with mixture A, drives conveyer belt to shake so that mixture by the gas of the second air pump
B and mixture A are uniformly mixed, and gas can also take away the heat in heating plate, prevent drug ingedient fragile in temperature relative superiority or inferiority
It is bad.2nd, it is shaped by the heating chamber in heating plate to effective ingredient, is fabricated to pellet, graininess or other shapes
Shape when drug enters human body, just has begun to be absorbed, also, human body is during absorption, the active ingredient absorbed
It is also that itself is required, human body can be promoted to get well.
In order to further verify caused advantageous effect in the present embodiment, following experiment has been done：
Comparative example 1：Using common plaster (Yunnan Baiyao of Yunnan Paiyao Group Corp., Ltd's production).
Contrast experiment is carried out to embodiment and comparative example 1, experimental result is as follows：
The effective of embodiment 1-4 is substantially higher relative to comparative example 1, and reason is：Secret ointment in the production process,
Fully the active ingredient of each drug, when entering human body, is just had begun to be absorbed, also, people to fully utilizing
Body can utmostly absorb each component drugs during absorption, and human body is promoted to get well.
Above-described is only the embodiment of the present invention, and the common sense such as well known concrete structure and characteristic are not made herein in scheme
Excessive description.It, without departing from the structure of the invention, can be with it should be pointed out that for those skilled in the art
Several modifications and improvements are made, these should also be considered as protection scope of the present invention, these all do not interfere with what the present invention was implemented
Effect and practical applicability.The scope of protection required by this application should be based on the content of the claims, in specification
The records such as specific embodiment can be used for explaining the content of claim.
Claims (6)
1. secret ointment, it is characterised in that：Its raw material includes the drug based on following mass fraction：7-30 parts of calamine, safflower
10-40 parts, 15-60 parts of myrrh, 14-50 parts of Radix Notoginseng, 7-30 parts of Radix Angelicae Sinensis, 15-60 parts of the radix paeoniae rubrathe, 15-50 parts of dalbergia wood, motherwort 10-
40 parts, 10-40 parts of cortex acanthopanacis.
2. secret ointment according to claim 1, it is characterised in that：Its raw material includes the medicine based on following mass fraction
Object：7 parts of calamine, 10 parts of safflower, 15 parts of myrrh, 14 parts of Radix Notoginseng, 7 parts of Radix Angelicae Sinensis, 15 parts of the radix paeoniae rubrathe, 15 parts of dalbergia wood, 10 parts of motherwort,
10 parts of cortex acanthopanacis.
3. secret ointment according to claim 1, it is characterised in that：Its raw material includes the medicine based on following mass fraction
Object：30 parts of calamine, 40 parts of safflower, 60 parts of myrrh, 50 parts of Radix Notoginseng, 30 parts of Radix Angelicae Sinensis, 60 parts of the radix paeoniae rubrathe, 50 parts of dalbergia wood, motherwort 40
Part, 40 parts of cortex acanthopanacis.
4. secret ointment according to claim 1, it is characterised in that：Its raw material includes the medicine based on following mass fraction
Object：24 parts of calamine, 35 parts of safflower, 57 parts of myrrh, 43 parts of Radix Notoginseng, 24 parts of Radix Angelicae Sinensis, 54 parts of the radix paeoniae rubrathe, 43 parts of dalbergia wood, motherwort 33
Part, 36 parts of cortex acanthopanacis.
5. secret ointment according to claim 1, it is characterised in that：Its raw material includes the drug based on following mass fraction
15 parts of calamine, 20 parts of safflower, 30 parts of myrrh, 25 parts of Radix Notoginseng, 15 parts of Radix Angelicae Sinensis, 30 parts of the radix paeoniae rubrathe, 25 parts of dalbergia wood, 20 parts of motherwort,
20 parts of cortex acanthopanacis.
6. according to the secret ointment described in claim 1-5 any one, it is characterised in that：Secret ointment is by following steps system
Into,
Step (1)：Calamine, safflower, myrrh, Radix Notoginseng, Radix Angelicae Sinensis, the radix paeoniae rubrathe, dalbergia wood, motherwort and cortex acanthopanacis are crushed into powder
Last shape, mixing of being sieved, obtains the mixture A of powdery；
Step (2)：200 parts -600 parts of edible vegetable oil is taken to be put into pot, decocts the 20-40 minutes fluid for forming drops；
Step (3)：12 parts -24 parts of yellow lead is taken to add in the fluid of step (2), mixture B is obtained, by mixture B by receiving cream
Device is stirred evenly and is heated, and temperature control is spent at 100 degree -210, obtains mixture C；
Step (4)：Mixture A in step (1) is put into receipts cream device, and is mixed with the mixture C of step (3)
Plaster is made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810276677.6A CN108245559A (en) | 2018-03-30 | 2018-03-30 | Secret ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810276677.6A CN108245559A (en) | 2018-03-30 | 2018-03-30 | Secret ointment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108245559A true CN108245559A (en) | 2018-07-06 |
Family
ID=62747678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810276677.6A Pending CN108245559A (en) | 2018-03-30 | 2018-03-30 | Secret ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108245559A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885905A (en) * | 2012-10-31 | 2013-01-23 | 王丽娟 | Powder for promoting blood circulation and relieving pain |
| CN105663341A (en) * | 2016-03-30 | 2016-06-15 | 吴美燕 | Preparation method of traditional Chinese medicine ointment for treating traumatic injury |
-
2018
- 2018-03-30 CN CN201810276677.6A patent/CN108245559A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885905A (en) * | 2012-10-31 | 2013-01-23 | 王丽娟 | Powder for promoting blood circulation and relieving pain |
| CN105663341A (en) * | 2016-03-30 | 2016-06-15 | 吴美燕 | Preparation method of traditional Chinese medicine ointment for treating traumatic injury |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106474418A (en) | For treating Chinese medicine composition of gastropathy and preparation method thereof | |
| CN107412612A (en) | A kind of health care anti-trioxypurine alternative tea and preparation method thereof | |
| CN108245559A (en) | Secret ointment | |
| CN105125361B (en) | The ventilating massage sick bed of anti-fall decubital ulcer | |
| CN104225283B (en) | A kind of oral medicinal herb medicine and plaster for treating cervical vertebra, scapulohumeral periarthritis, protrusion of lumber intervertebral disc, rheumatic arthritis and rheumatoid arthritis | |
| CN101239126A (en) | Chinese medicinal composition for promoting digestion of livestock and preparation thereof | |
| CN103341129A (en) | External-application medicine for treating sprained ankle | |
| CN102755584A (en) | Medicament for treating livestock diarrhea | |
| CN105194026A (en) | Traditional Chinese medicine composition used for treating non-infectious diarrhea of cage rearing chicken as well as preparation method and application thereof | |
| CN101204545B (en) | Medicine for shoulder periarthritis | |
| CN101041012B (en) | Compound Chinese traditional medicine for creating bone joint ligament loosing and dislocation | |
| CN105055095B (en) | The massage sick bed of anti-fall decubital ulcer | |
| CN108272938A (en) | Middle vulnerary | |
| CN103800874B (en) | A kind of pharmaceutical composition of fumigation treatment apoplexy hemiplegia limbs disturbance | |
| CN103920078B (en) | A kind of medicine for the treatment of cough with asthma and preparation method thereof | |
| CN102670699B (en) | Traditional Chinese medicine for curing internal hemorrhoid | |
| CN103638474B (en) | A kind of Chinese medicine for the treatment of atrophic gastritis | |
| CN103212013A (en) | Chinese medicinal composition for treating epigastric pain | |
| CN104491196A (en) | Traditional Chinese medicine preparation for treating gastrorrhagia | |
| CN107158138A (en) | A kind of external medicine composition for treating psoriasis vulgaris | |
| CN106581201A (en) | Medicine for treating heart heat wind evil | |
| CN106620203A (en) | Traditional Chinese medicine composition for treating laminitis of cows | |
| CN106138354A (en) | A kind of Chinese medicine treating cattle inappetence and preparation method thereof | |
| CN106071276A (en) | A kind of feedstuff Chinese medicine additive preventing and treating bamboo rat cold | |
| CN110680849A (en) | Oral traditional Chinese medicine formula for treating bone fracture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180706 |